에 대한 최신 뉴스 ONGold Resources (OTC:ONGRF) 주식

ONGold Resources Ltd is a mining company. Its project include TPK Property.

News

Small Cap Analysis

Commodities

Trading Ideas

NSUPF

ONGRF

SMDRF

VAULT INTELLIGENCE LTD by VAULT INTELLIGENCE LTD.

VLTLF

2025년까지 원자재의 긍정적인 추세가 계속될 것으로 보인다. 여러 지역에서 갈등과 불안정성이 심화됨에 따라, 안전한 관할권에 집중하는 주니어 원자재 상품 기업 목록을 살펴본다.

2025년 주목할 만한 원자재 상품주 4종목

ONGOLD RESOURCES LTD by ONGold Resources Ltd.

ONGold Resources Ltd

Arthur Hayes, co-founder of BitMEX on Thursday raised concerns over proposals for a strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve and a broad crypto regulatory bill, arguing that both initiatives could be <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43473182/could-the-trump-established-sovereign-wealth-fund-invest-in-bitcoin-nvidia-tiktok">detrimental to the cryptocurrency industry. </a>
What Happened: In a blog <a href="https://cryptohayes.medium.com/the-genie-348d557b4fd4">post</a>, he points out that government-controlled Bitcoin reserves would be used for political leverage rather than as a long-term economic strategy, leading to market uncertainty.
He also warns that a regulatory framework designed by policymakers would primarily benefit large financial institutions while sidelining independent builders and startups, another &#8220;net negative&#8221; for the industry.
Hayes contends that a government-backed Bitcoin reserve could introduce volatility into the market. 
If one administration aggressively accumulates Bitcoin, a future administration could just as easily sell off those holdings, using them to fund political agendas or economic relief programs. 
This unpredictability would undermine confidence in Bitcoin as a neutral asset.
He notes that political motivations, rather than financial strategy, would dictate the government&#8217;s Bitcoin policies, potentially leading to disruptive sell-offs.
He is equally critical of the regulatory approach being pushed by policymakers, arguing that overly prescriptive regulations would favor major firms like Coinbase and BlackRock, which have the resources to comply with complex legal requirements.
Startups and decentralized projects, by contrast, would struggle to navigate the regulatory landscape, effectively consolidating the power of established players at the expense of innovation.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43500853/is-the-sec-making-peace-with-crypto-the-key-personnel-shifts-hinting-at-why-this-may-be-the-case">Is The SEC &#8216;Making Peace&#8217; With Crypto? The Key Personnel Shifts Hinting At Why This May Be The Case</a>
Why It Matters: Hayes suggests that rather than enforcing a rigid regulatory framework, policymakers should focus on fostering an environment that encourages open and permissionless innovation.
Instead of a government-managed Bitcoin reserve, Hayes proposes that Bitcoin should be recognized as a neutral reserve asset that remains independent of state control. 
He suggests that a progressive approach to integrating Bitcoin into the global financial system would provide greater long-term stability than <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43270841/how-donald-trump-could-make-the-strategic-bitcoin-reserve-a-reality">direct government intervention.</a>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43494611/bitcoin-to-reach-500000-before-trump-leaves-office-standard-chartered">Bitcoin To Reach $500,000 Before Trump Leaves Office: Standard Chartered</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Arthur Hayes Blasts Strategic Bitcoin Reserve, Regulatory Bill As 'Net Negatives'

Evercore ISI Group analyst Steve Sakwa maintains Brandywine Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDN#NYSE">BDN</a>) with a In-Line and lowers the price target from $6 to $5.

Price Target

Analyst Ratings

Evercore ISI Group Maintains In-Line on Brandywine Realty Tr, Lowers Price Target to $5

Wells Fargo analyst Alec Brondolo maintains Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) with a Overweight and raises the price target from $63 to $68.

CRTO

Wells Fargo Maintains Overweight on Criteo, Raises Price Target to $68

WIIM

Prestige Consumer Healthcare shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 adjusted EPS guidance above estimates.

Evercore ISI Group analyst Vijay Kumar maintains Azenta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZTA#NASDAQ">AZTA</a>) with a In-Line and raises the price target from $50 to $52.

AZTA

Evercore ISI Group Maintains In-Line on Azenta, Raises Price Target to $52

Ralph Lauren Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">surging Thursday </a>after the third-quarter FY25 earnings result.
The luxury fashion company reported third-quarter sales growth of 11% year-on-year to $2.14 billion, beating the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43525774/ralph-lauren-reports-third-quarter-fiscal-2025-holiday-results-above-expectations-and-raises-full-" rel="noreferrer noopener">consensus estimate of $2.01 billion</a>.
Revenue growth was driven by better-than-expected holiday performance in all geographies. Global direct-to-consumer comparable store sales increased 12%.
Revenue in North America increased by 7% to $998 million,&nbsp;Europe jumped&nbsp;by 16% to $604 million, and&nbsp;Asia climbed by 14% to $507 million.
Gross profit was $1.5 billion, with a gross margin of 68.4%. Adjusted gross margin was also&nbsp;68.4%, 200 basis points above the prior year.
Operating margin was 18.2%, and operating income&nbsp;for the quarter&nbsp;jumped 22.6% to $389.7 million.&nbsp;Adjusted&nbsp;operating margin was 18.7%, 230 basis points above the prior year.
Adjusted EPS of $4.82 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus estimate of $4.49.</a>
The&nbsp;company held $2.14 billion in cash and equivalents&nbsp;as of December 28, 2024. Operating cash flow&nbsp;for nine months totaled $1.1 billion.
The company repurchased approximately $74 million of Class A Common Stock in the third quarter.
&#8220;Our teams around the world executed very well across geographies, channels, and categories this holiday to deliver on our long-term,&nbsp;Next Great Chapter: Accelerate&nbsp;strategy,&#8221; said Patrice Louvet, President and Chief Executive Officer.&nbsp;
Outlook: Ralph Lauren now expects FY25 revenues to increase&nbsp;6% &#8211; 7% (<a target="_blank" href="https://www.benzinga.com//node/41805217" rel="noreferrer noopener">prior view 3%&nbsp;to&nbsp;4%</a>) on a constant currency basis.
The company expects FY25 operating margin to expand 120 &#8211; 160 basis points (prior view &nbsp;110 &#8211; 130 basis points) in constant currency, driven by gross margin expansion 130 to 170 basis points (previous view 80 to 120 basis points)
For the fourth&nbsp;quarter, the company expects revenues to be&nbsp;up 6% &#8211; 7% on a constant currency basis.&nbsp;The company&nbsp;sees an operating margin expansion of 120 – 140 basis points in constant currency.
Ralph Lauren sees FY25 capital expenditures of $200 million to $250 million.
Price Action: RL shares are trading higher by 15.1% at $286.59 at the last check Thursday.
Photo via Shutterstock.

Earnings

Equities

Guidance

Movers

General

Luxury Fashion Company Ralph Lauren Q3 Revenue Surges 11% On Robust Holiday Sales; Stock Jumps

Wells Fargo analyst Michael Berg maintains CSG Systems Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGS#NASDAQ">CSGS</a>) with a Equal-Weight and raises the price target from $51 to $65.

CSGS

Wells Fargo Maintains Equal-Weight on CSG Systems Intl, Raises Price Target to $65

Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) shares are trading slightly <a href="http://benzinga.com/pressreleases/25/02/b43522213/hilton-reports-fourth-quarter-and-record-full-year-results" target="_blank" rel="noreferrer noopener">higher on Thursday</a> after the company reported fourth-quarter earnings that beat the Street consensus.
<ul>
<li>Q4 adjusted earnings per share of $1.76, beating the street view of $1.68. </li>
<li>Quarterly sales of $2.783 billion outpaced the analyst consensus estimate of $2.77 billion.</li>
<li>22,600 rooms added to Hilton&#8217;s system, resulting in 98,400 room openings for the full year.</li>
<li>This contributed to net unit growth of 7.3% from Dec. 31, 2023.</li>
<li>System-wide comparable Revenue Per Available Room, or RevPAR, in the quarter under review increased 3.5% year over year. Management and franchise fee revenues increased 4.8%.</li>
</ul>
CEO Christopher J. Nassetta said all segments drove RevPAR outperformance. Nassetta also cited strong trends in leisure occupancy, as well as continued growth in business transient and group results.
HIlton expects &#8220;favorable trends to continue into 2025,&#8221; Nassetta said.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/25/02/43518087/trump-meme-coin-jumps-4-27-outpaces-bitcoin-ethereum-and-dogecoin-but-its-still-no-where-near-january-highs" rel="noreferrer noopener">TRUMP Meme Coin Jumps 4.27%, Outpaces Bitcoin, Ethereum And Dogecoin, But It&#8217;s Still Nowhere Near January Highs</a>
&#8220;We also delivered the highest number of approvals, construction starts and openings in our history in 2024,&#8221; he added.
Adjusted EBITDA in the quarter under review totaled $858 million, higher than $803 million in the year-ago period.
As of Dec. 31, the company has $11.2 billion of debt outstanding. 
Outlook: Hilton expects first-quarter adjusted EPS to be between $1.57 and $1.63, below the $1.67 estimate.
Hilton has announced that it expects its first quarter system-wide RevPAR to increase by 2.5% to 3.5% year-over-year on a currency-neutral basis.
&#8220;With a development pipeline of nearly half a million rooms, we are confident that we are well positioned to deliver net unit growth between 6% and 7% in 2025,&#8221; the CEO said.
For 2025, it anticipates adjusted EPS of $7.71 to $7.82, higher than the $7.04 estimate. Additionally, the company has projected net unit growth for the full fiscal year 2025 (FY25) to be between 6% and 7%.
Price Action: HLT shares are trading higher by 5.72% to $272.60 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/02/43517995/amazons-remarkable-alexa-is-coming-heres-what-to-expect-from-the-ai-overhaul-and-its-potential-10-monthly-fee" target="_blank" rel="noreferrer noopener">Amazon's ‘Remarkable Alexa' Is Coming—Here's What To Expect From The AI Overhaul And Its Potential $10 Monthly Fee</a></li>
</ul>

Markets

Hilton Stock Soars As Q4 Beats Estimates Amid Strength In Revenue Per Available Room

Wells Fargo analyst Andrew Bauch maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Overweight and raises the price target from $240 to $270.

Wells Fargo Maintains Overweight on Fiserv, Raises Price Target to $270

Lincoln National shares are trading higher after the company reported better-than-expected Q4 financial results.

Wedbush analyst Seth Basham maintains O'Reilly Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) with a Neutral and raises the price target from $1200 to $1350.

ORLY

Wedbush Maintains Neutral on O'Reilly Automotive, Raises Price Target to $1350

On Wednesday, Becton, Dickinson and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>) authorized to pursue a plan to separate BD&#8217;s Biosciences and Diagnostic Solutions business from the rest of BD to enhance strategic focus, and growth-oriented investments <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43511126/bd-announces-intent-to-separate-biosciences-and-diagnostic-solutions-business-to-enhance-focus-dri" rel="noreferrer noopener">and capital allocation</a>.
Following the separation, New BD will be a pure-play medical technology company. It expects to drive concentrated investments in high-impact R&amp;D and disciplined capital allocation, including growth-accretive M&amp;A.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43443889/starboard-value-pushes-becton-dickinson-to-divest-life-sciences-unit" rel="noreferrer noopener">Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit</a>
Medical Essentials includes BD&#8217;s Medication Delivery Solutions and Specimen Management businesses, which manufacture products such as IV catheters, PICCS, flush and other essential vascular access and management solutions, blood collection solutions, syringes, and advanced needle technologies.
Connected Care includes BD&#8217;s Medication Management Solutions and Advanced Patient Monitoring businesses with smart devices that use automation, artificial intelligence, and analytics.
BioPharma Systems provides biologic drug delivery, development, and manufacturing of drug delivery devices for the pharmaceutical industry.
Interventional, which includes BD&#8217;s Urology &amp; Critical Care, Peripheral Intervention, and Surgery businesses, caters to conditions such as urinary incontinence, peripheral vascular disease, cancer, and hernias.
After the separation, the New BD is expected to have fiscal 2024 revenue of approximately&nbsp;$17.8 billion. Biosciences and Diagnostic Solutions is expected to have approximately&nbsp;$3.4 billion&nbsp;in fiscal 2024 revenue.
The company expects to announce more specifics on the separation plans by the end of fiscal 2025 and intends to target completion of the transaction in fiscal 2026.
In April 2022, Becton Dickinson spun off&nbsp;Embecta Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NYSE">EMBC</a>), a diabetes device maker, <a target="_blank" href="https://www.benzinga.com/25/02/43443889/starboard-value-pushes-becton-dickinson-to-divest-life-sciences-unit" rel="noreferrer noopener">into a standalone entity</a>.
In November, the company announced that it had decided to discontinue its insulin patch pump program and would&nbsp;<a target="_blank" href="https://www.benzinga.com/24/11/42197315/becton-dickinson-spinoff-embecta-stops-insulin-patch-pump-program-plans-restructuring-stock-jumps" rel="noreferrer noopener">initiate a restructuring plan</a>.
In July, Embecta, a manufacturer of disposable&nbsp;insulin pen needles&nbsp;and syringes, said it is considering a potential sale following a significant drop in its share price since being spun off from health tech&nbsp;<a target="_blank" href="https://www.benzinga.com/m-a/24/07/39916116/insulin-device-maker-embecta-weighs-sale-after-70-share-decline-following-becton-dickinson-spin-off" rel="noreferrer noopener">giant&nbsp;Becton, Dickinson</a>.
Concurrently, BD reported first-quarter 2025 adjusted EPS of $3.43 beating the consensus of $2.98. The company&#8217;s sales increased 9.8% year-over-year to $5.17 billion, beating the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">consensus of $5.1 billion</a>.
Guidance: BD updated its fiscal year 2025 revenue guidance from $21.9 billion-$22.1 billion to $21.7 billion-$21.9 billion compared to the consensus of $21.93 billion.
The company expects adjusted EPS of $14.30-$14.60, up from $14.25-$14.60 compared to the consensus of $14.40.
Price Action: BDX stock is down 3.88% at $235.56 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43527607/conocophillips-beats-q4-revenue-and-eps-estimates-sets-10b-return-of-capital-target" target="_blank" rel="noreferrer noopener">ConocoPhillips Beats Q4 Revenue And EPS Estimates, Sets $10B Return of Capital Target</a></li>
</ul>

Health Care

EMBC

Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business

Evercore ISI Group analyst Elizabeth Anderson maintains Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Outperform and raises the price target from $240 to $260.

ALGN

Evercore ISI Group Maintains Outperform on Align Tech, Raises Price Target to $260

Wells Fargo analyst Joe O'Dea maintains Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) with a Overweight and raises the price target from $92 to $98.

Wells Fargo Maintains Overweight on Johnson Controls Intl, Raises Price Target to $98

NVST

Envista Holdings shares are trading higher after the company reported better-than-expected Q4 financial results. Also, Wells Fargo and Morgan Stanley raised their respective price targets on the stock.

Wells Fargo analyst Joseph O'Dea maintains Illinois Tool Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) with a Underweight and lowers the price target from $250 to $245.

Wells Fargo Maintains Underweight on Illinois Tool Works, Lowers Price Target to $245

Darling Ingredients shares are trading higher after the company reported better-than-expected Q4 EPS results.

Wedbush analyst Seth Basham reiterates Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Neutral and maintains $250 price target.

Reiteration

CVNA

Wedbush Reiterates Neutral on Carvana, Maintains $250 Price Target

CENT

Central Garden shares are trading higher after the company reported better-than-expected Q1 financial results.

Wells Fargo analyst Joseph O'Dea maintains Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) with a Overweight and raises the price target from $140 to $142.

Wells Fargo Maintains Overweight on Emerson Electric, Raises Price Target to $142

ONGold announces private placement

Press Releases

Northern Superior Announces ONGold's Agreements to Acquire Monument Bay and Domain Gold Projects in Manitoba

Northern Superior Confirms Availability of Shareholder Meeting Materials

Northern Superior Announces ONGold's Completion of Monument Bay and Domain Projects Acquisition in Manitoba

Northern Superior Announces Board Recalibration to Original Size

TSX:AEM

TSX:SUP

TSXV:CMIL

TSXV:ONAU

TSXV:SUP

ONGold Resources

2025년까지 원자재의 긍정적인 추세가 계속될 것으로 보인다. 여러 지역에서 갈등과 불안정성이 심화됨에 따라, 안전한 관할권에 집중하는 <a href="https://www.benzinga.com/markets/commodities" target="_blank" rel="noreferrer noopener">주니어 원자재 상품 기업</a> 목록을 살펴본다.
<h2>볼트 리튬</h2>
볼트 리튬(OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/VLTLF#OTCQB">VLTLF</a>)는 <a href="https://www.benzinga.com/markets/commodities/24/06/39480795/exclusive-volt-lithium-ceo-touts-6b-cash-flow-opportunity" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">유전 염수에서 리튬 추출</a>을 위한 기술 발전에 주력하는 캐나다의 주니어 자원 회사이다. 이 회사는 독점적인 직접 <a href="https://www.benzinga.com/markets/commodities/24/06/39480795/exclusive-volt-lithium-ceo-touts-6b-cash-flow-opportunity" target="_blank" rel="noreferrer noopener">리튬 추출 기술</a>을 통해 총 생산 비용을 톤당 2,900달러 미만으로 달성할 수 있으므로 염수 기반 리튬의 최초 상업적 생산자가 되는 것을 목표로 하고 있다. 리튬 가격은 2022년 최고치인 8만 달러에서 하락한 후에도 톤당 1만 달러 선을 맴돌고 있다.
경험이 풍부한 기업가인 알렉스 와일리(Alex Wylie)의 리더십 아래, 이 회사는 텍사스 퍼미안 분지에 테스트 시설을 설립했다. 다음 이정표는 이 회사가 하루에 10,000배럴의 유전 염수를 처리할 수 있는 차세대 현장 장치를 시운전할 계획인 다음 몇 주에 걸쳐 예정되어 있다. 주가는 연초 대비 11.61% 상승했다.
<h2>노던 슈피리어</h2>
노던 슈피리어(OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NSUPF#OTCQB">NSUPF</a>)는 퀘벡과 온타리오에 프로젝트를 둔 주니어 금광 회사이다. 이 회사는 치부가마우(Chibougamau) 광산 지구를 개발하는 데 주력하고 있으며, 여기에서 <a href="https://www.benzinga.com/markets/commodities/24/08/40135946/exclusive-northern-superior-ceo-simon-marcotte-explains-companys-strategic-expansion-future-p" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">300만 온스 이상</a>의 금 매장량을 보유한 4개 사이트를 소유하고 있다. 이 자원들은 물리적으로 가까이 위치해 있어 단일 운영 설계를 지원하고 단일 제련소에 공급할 수 있다.
CEO 사이먼 마코트(Simon Marcotte)는 벤징가와의 인터뷰에서 &#8220;치부가마우 금 캠프는 증가하는 관심을 받고 있으며, 퀘벡 최대 은행인 내셔널 뱅크(National Bank)와 캠프를 아이엠골드(IAMGOLD)의 다음 성장 단계로 확인한 아이엠골드의 주관회사를 포함한다&#8221;고 말했다. 마코트는 2025년에도 이 부문에서 긍정적인 M&amp;A 트렌드가 계속될 것으로 예상하고, 퀘벡과 같은 최고의 관할권에 집중할 것이라고 밝혔다.
또한 이 회사는 자사의 온타리오 자산을 온골드 리소스(OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/ONGRF#OTCQB">ONGRF</a>)로 분사하였으며, 노던 슈피리어는 62% 지분을 보유하고 있다. 애그니코 이글 마인스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEM#NYSE">AEM</a>)는 세계 3위 금 생산업체로 15% 지분을 보유하고 있다. 노던 슈피리어의 주가는 올해 들어 7.25% 하락했다.
<h2>시에라 마드레 골드 앤 실버</h2>
시에라 마드레 골드 앤 실버(OTC:<a class="ticker" href="https://www.benzinga.com/stock/SMDRF#OTC">SMDRF</a>)는 캐나다와 멕시코에서 프로젝트에 주력하는 광물 탐사 회사이다. 이 회사의 대표 프로젝트는 멕시코 톨루카 근처에 위치한 기타라(Guitarra) 은-금 광산이다. 이 프로젝트는 지하에서 운영되기 때문에, 국가에서 논의되고 있는 노천 광산 채굴 금지의 잠재적 영향을 받지 않는다.
이 프로젝트의 총 자원 추정치는 20만 온스의 금과 3,300만 온스 이상의 은이다. 테스트 활동은 이미 250만 달러 이상의 매출을 창출했으며, 전체 상업 채굴 발표가 즉시 예상된다. 주가는 올해 들어 12.50% 상승했다.
<h2>프리드만 인더스트리스</h2>
프리드만 인더스트리스(AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FRD#AMEX">FRD</a>)는 국내 철강 제조업체이다. 지난 50년 동안, 이 회사는 북부 및 중부 미국에서 주목할 만한 운영자로 자리 잡았다. 도널드 트럼프의 두 번째 임기가 1월 20일 시작되면서, 국내 철강 부문은 그의 &#8220;미국 우선&#8221; 정책의 초점이 될 것이며, 첫 번째 임기에는 철강 수입에 25% 관세가 포함되었다. 트럼프의 일본제철의 US 스틸 인수에 대한 반대는 조 바이든 대통령과 카멀라 해리스 부통령과의 <a href="https://www.benzinga.com/markets/equities/24/10/41445066/as-trump-kamala-harris-and-biden-unite-against-nippon-steels-15b-us-steel-acquisition-japanese-s" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">의견이 일치한</a> 드문 사례였다.
프리드만 인더스트리스는 11.7%의 높은 헤지 펀드 소유율과 4.8%의 내부자 소유율을 가진 비정상적인 소유 구조를 가지고 있으며, 내부자들은 2024년에만 매입하고 있다. 주가는 올해 들어 2.52% 하락했다.
 
다음 읽기: <a href="https://www.benzinga.com/analyst-ratings/price-target/24/12/42672565/why-trumps-return-to-office-could-drive-gold-demand-in-2025" target="_blank" rel="noreferrer noopener">트럼프의 재임이 2025년 금 수요에 미칠 영향</a>
사진 출처: Shutterstock


다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

ONGold Resources

뉴스

에 대한 최신 뉴스 ONGold Resources (OTC:ONGRF) 주식

화요일, 12월 31, 2024

뉴스

파트너 / 기고자

벤징가 글로벌